| Literature DB >> 32658736 |
B Robson1.
Abstract
SARS-CoV andEntities:
Keywords: Bioinformatics; COVID-19; Coronavirus; Prediction of sialic acid binding; S1-NTD; SARS-CoV-2; Sialic acid; Spike glycoprotein; Spike protein; Sugar binding
Mesh:
Substances:
Year: 2020 PMID: 32658736 PMCID: PMC7278709 DOI: 10.1016/j.compbiomed.2020.103849
Source DB: PubMed Journal: Comput Biol Med ISSN: 0010-4825 Impact factor: 4.589
Fig. 1Spike protein of SARS-CoV-2 PDB entry 6VVX, showing S1-NTD domain (dark blue). See text in regard to the significance of the other colors.
One letter amino acid codes and sialic acid site binding region measures discussed in the text.
| One letter code | Amino acid | Conservative replacements | Preliminary sialic acid binding amino acid score SABS (see Results) | SABR-P prediction method refined parameters (see Results) |
|---|---|---|---|---|
| A | alanine | A, E, S, T | 1 | 1 |
| C | cysteine/cystine | S, T, V | 1 | 1 |
| D | aspartic acid | E | 1 | 1 |
| E | glutamic acid | A, D | 0 | 0 |
| F | phenylalanine | M, W, Y | 1 | 2 |
| G | glycine | N, P | 1 | 1 |
| H | histidine | K, R | 1 | 2 |
| I | isoleucine | L, V | 0 | 0 |
| K | lysine | H, R | 0 | 0 |
| L | leucine | I, V | 0 | 0 |
| M | methionine | F, W, Y | 0 | 0 |
| N | asparagine | G, D, Q | 1 | 1 |
| P | proline | G | 0 | 0 |
| Q | glutamine | N, E | 0 | 0 |
| R | arginine | H, K | 0 | 0 |
| S | serine | A, T | 1 | 1 |
| T | threonine | A, I, S | 1 | 1 |
| V | valine | A, I, L | 0 | 0 |
| W | tryptophan | F, M, Y | 2 | 4 |
| Y | tyrosine | F. M, W | 1 | 2 |
Fig. 2The influenza virus B neuraminidase tryptophan interaction with and sialic Acid(PDB entry 2BAT).
Fig. 3S1-NTD (PDB 6VXX) Showing Residues at Boundaries of Invisible (Disordered) Segments and the Location of the Two Visible Tryptophan (TRP) Residues. These are the last visible residues of the non-disordered region bounding a disordered region, and this figure shows how the missing sections result in “cut ends” in displays of the reported three dimensional structure.
Sialic acid binding scores and surface exposure of tryptophan -containing subsequences.
| Subsequence | Protein | GenBank or PDB entry | Score | Experimental observation or exposure suggested by structural analogy |
|---|---|---|---|---|
| FFSNVTWFHAIHVSGTN | SARS-CoV-2 S1-NTD | MN908947.3 | 0.88 | Tryptophan exposed |
| FYSNVTGFHTIHTFGNP | SARS-CoV S1-NTD | NP_828851.1 | 0.82 | Site aligning with above, no tryptophan, exposed |
| SNIIRGWIFGTTLDSKT | SARS-CoV | MN908947.3 | 0.71 | Example of buried Tryptophan, but possibly accessible at base of cleft |
| HDGGKTWHSAATAIYCA | neuraminidase Influenza B | PDB 1NSB | 0.94 | Tryptophan exposed |
| EGKQGNFKNLREFVFKN | SARS-CoV-2 S1-NTD | MN908947.3 | 0.47 | Aligns with a Zhang-Yap binding site |
| SEKSGNFKHLREFVFKN | SARS-CoV | NP_828851.1 | 0.53 | Aligns with a Zhang-Yap binding site |
| KAGNSIFRSFHFTDFYN | Hemagglutinin esterase | PDB 3CL5 | 0.88 | Aligns with a Zhang-Yap binding site |
| SAGDSIFKSYHFTRFYN | CoV - E3 | PDB 4EB1.1 | 0.82 | Aligns with a Zhang-Yap binding site |
| GDSSSGWTAGAAAYYVG | SARS-CoV-2 | MN908947.3 | 0.94 | Aligns with a Zhang-Yap binding site |
| SPAQDIWGTSAAAYFVG | SARS-CoB | NP_828851.1 | 0.82 | Aligns with a Zhang-Yap binding site |
| SGSNDIWMQNKGLFYTQ | Hemagglutinin esterase | PDB 3CL5 | 0.71 | Aligns with Zhang-Yap binding site |
| NGSNDVWIFNKVRFYRA | CoV - E3 | Q14EB1.1 | 0.71 | Aligns with Zhang-Yap binding site |
Fig. 4Examples of Prediction of Sialic Acid Binding Sites by SABR-P.
In each case, the abscissa (x axis) is the distance along the sequence (residue number) and the ordinate (y axis) is the predicted sialic acid glycan binding propensity. Scores above a threshold of 100 (red line) for any residues are taken as a prediction that the domain or protein binds sialic acid glycans.
Fig. 5Prediction of sialic acid glycan binding regions applied to the SARS-CoV-2 spike glycoprotein sequence.
Fig. 6The Tryptophan sidechain in FFSNVTWFHAIHV 58–70 of Spike Glycoprotein is Exposed in a Site that Has all the Appearance of a Sialic Acid Glycan binding site.